Industry: Medical Devices & Consumables
Published Date: 2025-12-12
Pages: 81 Pages
Report ld: 5541459
Request Sample
Customized Report
Birth Control Patch Market Size(US$)

CAGR 2025-2031
13.5%
Market Size,2031
USD 37.47
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Birth Control Patch was estimated to be worth US$ 14.78 million in 2024 and is forecast to a readjusted size of US$ 37.47 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Birth Control Patch cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Birth Control Patch production reached approximately 132 k units, with an average global market price of around US$ 112 per unit. In 2024, the global 's total production capacity of Birth Control Patch reached 160 k units.The industry average gross profit margin of this product reached 23%.
Birth control patches are a non-oral hormonal contraceptive method that uses the skin to continuously release estrogen and progesterone to achieve contraception. They have gained attention due to their convenience and high compliance. The core function of the contraceptive patch is to release hormones, which prevent pregnancy by inhibiting ovulation, thickening cervical mucus to block sperm, and thinning the uterine lining to make it unsuitable for implantation. The upstream sector primarily includes suppliers of active pharmaceutical ingredients (hormonal raw materials, such as estrogen and progesterone), manufacturers of specialized transdermal drug delivery matrix materials (such as adhesives and penetration enhancers), and research institutions or biotechnology companies developing drug delivery systems. This segment has high technological barriers, especially regarding the extremely high requirements for hormone purity and the stability of transdermal technology. Therefore, suppliers are relatively concentrated, typically having deep collaborations or long-term supply relationships with leading midstream pharmaceutical companies. Raw material costs and quality directly determine the efficacy and safety of the final product. The midstream sector is the core of the industry chain, dominated by pharmaceutical companies possessing transdermal formulation technology and production capabilities. They are responsible for converting upstream raw materials into finished patches and performing rigorous aseptic filling, slitting, and packaging. This segment is capital- and technology-intensive, requiring compliance with GMP standards of major global pharmaceutical regulatory systems (such as the US FDA and EU EMA). New production lines require significant investment and have lengthy approval cycles. Companies build competitive barriers through patent protection and brand marketing, while some outsource production to professional contract research and development (CDR) organizations. The downstream sector involves the distribution network and payment system for delivering products to consumers. In mature markets, products are primarily distributed through prescription drug channels: prescribed by doctors and sold through hospital pharmacies or retail pharmacies, with costs largely covered or reimbursed by medical insurance institutions. Therefore, academic promotion with medical institutions and inclusion in the medical insurance catalog are crucial. In regions where contraceptive patches have not yet been approved (such as mainland China), the downstream formal market is virtually nonexistent, with only a very small amount of products potentially entering the market through personal channels, and no legitimate supply chain has been established. The end users are primarily women of childbearing age with long-term, convenient contraceptive needs.
The growing global emphasis on women's reproductive health rights is translating into substantial policy support. Many governments and international organizations are incorporating the accessibility of modern contraceptives into public health goals, potentially reducing out-of-pocket costs for users through expanded health insurance catalogs and procurement subsidies. Particularly in emerging markets with huge potential, such as China and Southeast Asia, product approval by local regulatory agencies will directly open up substantial new markets. Simultaneously, the rise of online health platforms and the facilitation of prescription transfers provide new pathways for market education and distribution of compliant products.
Modern women's increasing demands for reproductive autonomy and the "controllability" of contraceptive methods are driving a shift from short-acting, easily missed methods to long-acting, convenient, and reversible contraceptive methods. The "once-a-week" requirement of contraceptive patches perfectly caters to users who prioritize convenience. Furthermore, public awareness of hormonal drugs is becoming more rational, moving away from fear of hormones and focusing more on product effectiveness and personalized experience. In addition, in some markets, safety concerns surrounding traditional oral contraceptives due to potential blood clot risks have created alternative growth opportunities for transdermal delivery methods such as patches. Technological breakthroughs are fundamental to driving the long-term development of the industry. Current R&D focus is shifting from single-function contraception to "multifunctional preventative technologies (MPTs)," namely, developing composite patches that can simultaneously prevent sexually transmitted infections (STIs) such as HIV, which is expected to revolutionize product value. Furthermore, improving polymer matrices, using novel penetration enhancers to improve hormone delivery efficiency and reduce local skin reactions, or developing products with more personalized dosages are all key R&D directions for enhancing user experience and compliance, and are expected to form new technological barriers and market growth points.
This report aims to provide a comprehensive presentation of the global market for Birth Control Patch, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Birth Control Patch by region & country, by Type, and by Application.
The Birth Control Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Birth Control Patch.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Birth Control Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Birth Control Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Birth Control Patch in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Birth Control Patch Product Introduction
1.2 Global Birth Control Patch Market Size Forecast
1.2.1 Global Birth Control Patch Sales Value (2020-2031)
1.2.2 Global Birth Control Patch Sales Volume (2020-2031)
1.2.3 Global Birth Control Patch Sales Price (2020-2031)
1.3 Birth Control Patch Market Trends & Drivers
1.3.1 Birth Control Patch Industry Trends
1.3.2 Birth Control Patch Market Drivers & Opportunity
1.3.3 Birth Control Patch Market Challenges
1.3.4 Birth Control Patch Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Birth Control Patch Players Revenue Ranking (2024)
2.2 Global Birth Control Patch Revenue by Company (2020-2025)
2.3 Global Birth Control Patch Players Sales Volume Ranking (2024)
2.4 Global Birth Control Patch Sales Volume by Company Players (2020-2025)
2.5 Global Birth Control Patch Average Price by Company (2020-2025)
2.6 Key Manufacturers Birth Control Patch Manufacturing Base and Headquarters
2.7 Key Manufacturers Birth Control Patch Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Birth Control Patch
2.9 Birth Control Patch Market Competitive Analysis
2.9.1 Birth Control Patch Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Birth Control Patch Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Birth Control Patch as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Seven Days Replacement
3.1.2 Three Days Replacement
3.2 Global Birth Control Patch Sales Value by Type
3.2.1 Global Birth Control Patch Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Birth Control Patch Sales Value, by Type (2020-2031)
3.2.3 Global Birth Control Patch Sales Value, by Type (%) (2020-2031)
3.3 Global Birth Control Patch Sales Volume by Type
3.3.1 Global Birth Control Patch Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Birth Control Patch Sales Volume, by Type (2020-2031)
3.3.3 Global Birth Control Patch Sales Volume, by Type (%) (2020-2031)
3.4 Global Birth Control Patch Average Price by Type (2020-2031)
4 Segmentation by Hormone Combination Type
4.1 Introduction by Hormone Combination Type
4.1.1 Estrogen-Progestin Combined Patch
4.1.2 Progestin-Only Patch
4.2 Global Birth Control Patch Sales Value by Hormone Combination Type
4.2.1 Global Birth Control Patch Sales Value by Hormone Combination Type (2020 VS 2024 VS 2031)
4.2.2 Global Birth Control Patch Sales Value, by Hormone Combination Type (2020-2031)
4.2.3 Global Birth Control Patch Sales Value, by Hormone Combination Type (%) (2020-2031)
4.3 Global Birth Control Patch Sales Volume by Hormone Combination Type
4.3.1 Global Birth Control Patch Sales Volume by Hormone Combination Type (2020 VS 2024 VS 2031)
4.3.2 Global Birth Control Patch Sales Volume, by Hormone Combination Type (2020-2031)
4.3.3 Global Birth Control Patch Sales Volume, by Hormone Combination Type (%) (2020-2031)
4.4 Global Birth Control Patch Average Price by Hormone Combination Type (2020-2031)
5 Segmentation by Drug Release Mode
5.1 Introduction by Drug Release Mode
5.1.1 Rate-controlled
5.1.2 Reservoir-type
5.2 Global Birth Control Patch Sales Value by Drug Release Mode
5.2.1 Global Birth Control Patch Sales Value by Drug Release Mode (2020 VS 2024 VS 2031)
5.2.2 Global Birth Control Patch Sales Value, by Drug Release Mode (2020-2031)
5.2.3 Global Birth Control Patch Sales Value, by Drug Release Mode (%) (2020-2031)
5.3 Global Birth Control Patch Sales Volume by Drug Release Mode
5.3.1 Global Birth Control Patch Sales Volume by Drug Release Mode (2020 VS 2024 VS 2031)
5.3.2 Global Birth Control Patch Sales Volume, by Drug Release Mode (2020-2031)
5.3.3 Global Birth Control Patch Sales Volume, by Drug Release Mode (%) (2020-2031)
5.4 Global Birth Control Patch Average Price by Drug Release Mode (2020-2031)
6 Segmentation by Brand
6.1 Introduction by Brand
6.1.1 Original Brand Patch
6.1.2 Imitation Patch
6.2 Global Birth Control Patch Sales Value by Brand
6.2.1 Global Birth Control Patch Sales Value by Brand (2020 VS 2024 VS 2031)
6.2.2 Global Birth Control Patch Sales Value, by Brand (2020-2031)
6.2.3 Global Birth Control Patch Sales Value, by Brand (%) (2020-2031)
6.3 Global Birth Control Patch Sales Volume by Brand
6.3.1 Global Birth Control Patch Sales Volume by Brand (2020 VS 2024 VS 2031)
6.3.2 Global Birth Control Patch Sales Volume, by Brand (2020-2031)
6.3.3 Global Birth Control Patch Sales Volume, by Brand (%) (2020-2031)
6.4 Global Birth Control Patch Average Price by Brand (2020-2031)
7 Segmentation by Application
7.1 Introduction by Application
7.1.1 Online Sales
7.1.2 Offline Sales
7.2 Global Birth Control Patch Sales Value by Application
7.2.1 Global Birth Control Patch Sales Value by Application (2020 VS 2024 VS 2031)
7.2.2 Global Birth Control Patch Sales Value, by Application (2020-2031)
7.2.3 Global Birth Control Patch Sales Value, by Application (%) (2020-2031)
7.3 Global Birth Control Patch Sales Volume by Application
7.3.1 Global Birth Control Patch Sales Volume by Application (2020 VS 2024 VS 2031)
7.3.2 Global Birth Control Patch Sales Volume, by Application (2020-2031)
7.3.3 Global Birth Control Patch Sales Volume, by Application (%) (2020-2031)
7.4 Global Birth Control Patch Average Price by Application (2020-2031)
8 Segmentation by Region
8.1 Global Birth Control Patch Sales Value by Region
8.1.1 Global Birth Control Patch Sales Value by Region: 2020 VS 2024 VS 2031
8.1.2 Global Birth Control Patch Sales Value by Region (2020-2025)
8.1.3 Global Birth Control Patch Sales Value by Region (2026-2031)
8.1.4 Global Birth Control Patch Sales Value by Region (%), (2020-2031)
8.2 Global Birth Control Patch Sales Volume by Region
8.2.1 Global Birth Control Patch Sales Volume by Region: 2020 VS 2024 VS 2031
8.2.2 Global Birth Control Patch Sales Volume by Region (2020-2025)
8.2.3 Global Birth Control Patch Sales Volume by Region (2026-2031)
8.2.4 Global Birth Control Patch Sales Volume by Region (%), (2020-2031)
8.3 Global Birth Control Patch Average Price by Region (2020-2031)
8.4 North America
8.4.1 North America Birth Control Patch Sales Value, 2020-2031
8.4.2 North America Birth Control Patch Sales Value by Country (%), 2024 VS 2031
8.5 Europe
8.5.1 Europe Birth Control Patch Sales Value, 2020-2031
8.5.2 Europe Birth Control Patch Sales Value by Country (%), 2024 VS 2031
8.6 Asia Pacific
8.6.1 Asia Pacific Birth Control Patch Sales Value, 2020-2031
8.6.2 Asia Pacific Birth Control Patch Sales Value by Region (%), 2024 VS 2031
8.7 South America
8.7.1 South America Birth Control Patch Sales Value, 2020-2031
8.7.2 South America Birth Control Patch Sales Value by Country (%), 2024 VS 2031
8.8 Middle East & Africa
8.8.1 Middle East & Africa Birth Control Patch Sales Value, 2020-2031
8.8.2 Middle East & Africa Birth Control Patch Sales Value by Country (%), 2024 VS 2031
9 Segmentation by Key Countries/Regions
9.1 Key Countries/Regions Birth Control Patch Sales Value Growth Trends, 2020 VS 2024 VS 2031
9.2 Key Countries/Regions Birth Control Patch Sales Value and Sales Volume
9.2.1 Key Countries/Regions Birth Control Patch Sales Value, 2020-2031
9.2.2 Key Countries/Regions Birth Control Patch Sales Volume, 2020-2031
9.3 United States
9.3.1 United States Birth Control Patch Sales Value, 2020-2031
9.3.2 United States Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.3.3 United States Birth Control Patch Sales Value by Application, 2024 VS 2031
9.4 Europe
9.4.1 Europe Birth Control Patch Sales Value, 2020-2031
9.4.2 Europe Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.4.3 Europe Birth Control Patch Sales Value by Application, 2024 VS 2031
9.5 China
9.5.1 China Birth Control Patch Sales Value, 2020-2031
9.5.2 China Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.5.3 China Birth Control Patch Sales Value by Application, 2024 VS 2031
9.6 Japan
9.6.1 Japan Birth Control Patch Sales Value, 2020-2031
9.6.2 Japan Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.6.3 Japan Birth Control Patch Sales Value by Application, 2024 VS 2031
9.7 South Korea
9.7.1 South Korea Birth Control Patch Sales Value, 2020-2031
9.7.2 South Korea Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.7.3 South Korea Birth Control Patch Sales Value by Application, 2024 VS 2031
9.8 Southeast Asia
9.8.1 Southeast Asia Birth Control Patch Sales Value, 2020-2031
9.8.2 Southeast Asia Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.8.3 Southeast Asia Birth Control Patch Sales Value by Application, 2024 VS 2031
9.9 India
9.9.1 India Birth Control Patch Sales Value, 2020-2031
9.9.2 India Birth Control Patch Sales Value by Type (%), 2024 VS 2031
9.9.3 India Birth Control Patch Sales Value by Application, 2024 VS 2031
10 Company Profiles
10.1 Viatris
10.1.1 Viatris Company Information
10.1.2 Viatris Introduction and Business Overview
10.1.3 Viatris Birth Control Patch Sales, Revenue, Price and Gross Margin (2020-2025)
10.1.4 Viatris Birth Control Patch Product Offerings
10.1.5 Viatris Recent Development
10.2 Agile Therapeutics
10.2.1 Agile Therapeutics Company Information
10.2.2 Agile Therapeutics Introduction and Business Overview
10.2.3 Agile Therapeutics Birth Control Patch Sales, Revenue, Price and Gross Margin (2020-2025)
10.2.4 Agile Therapeutics Birth Control Patch Product Offerings
10.2.5 Agile Therapeutics Recent Development
10.3 Ortho-McNeil Pharmaceuticals
10.3.1 Ortho-McNeil Pharmaceuticals Company Information
10.3.2 Ortho-McNeil Pharmaceuticals Introduction and Business Overview
10.3.3 Ortho-McNeil Pharmaceuticals Birth Control Patch Sales, Revenue, Price and Gross Margin (2020-2025)
10.3.4 Ortho-McNeil Pharmaceuticals Birth Control Patch Product Offerings
10.3.5 Ortho-McNeil Pharmaceuticals Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Birth Control Patch Sales, Revenue, Price and Gross Margin (2020-2025)
10.4.4 Mylan Birth Control Patch Product Offerings
10.4.5 Mylan Recent Development
10.5 Lvye Pharma
10.5.1 Lvye Pharma Company Information
10.5.2 Lvye Pharma Introduction and Business Overview
10.5.3 Lvye Pharma Birth Control Patch Sales, Revenue, Price and Gross Margin (2020-2025)
10.5.4 Lvye Pharma Birth Control Patch Product Offerings
10.5.5 Lvye Pharma Recent Development
11 Industry Chain Analysis
11.1 Birth Control Patch Industrial Chain
11.2 Birth Control Patch Upstream Analysis
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.2.3 Manufacturing Cost Structure
11.3 Midstream Analysis
11.4 Downstream Analysis (Customers Analysis)
11.5 Sales Model and Sales Channels
11.5.1 Birth Control Patch Sales Model
11.5.2 Sales Channel
11.5.3 Birth Control Patch Distributors
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Birth Control Patch market was valued at US$ 17.52 million in 2025 and is anticipated to reach US$ 42.03 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 93
USD 2900.00
(Single User License)
The global Birth Control Patch market size was US$ 17.52 million in 2025 and is forecast to reach a readjusted size of US$ 42.03 million by 2032 with a CAGR of 13.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 67
USD 4250.00
(Single User License)
The global market for Birth Control Patch was estimated to be worth US$ 17.52 million in 2025 and is projected to reach US$ 42.03 million, growing at a CAGR of 13.5% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 89
USD 3950.00
(Single User License)
The global Birth Control Patch market size was US$ 14.78 million in 2024 and is forecast to a readjusted size of US$ 37.47 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 72
USD 4250.00
(Single User License)
The global Birth Control Patch market is projected to grow from US$ 14.78 million in 2024 to US$ 37.47 million by 2031, at a CAGR of 13.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-12-12
Pages: 115
USD 4900.00
(Single User License)
The global market for Birth Control Patch was valued at US$ 14.78 million in the year 2024 and is projected to reach a revised size of US$ 37.47 million by 2031, growing at a CAGR of 13.5% during the forecast period.
Published Date: 2025-12-12
Pages: 104
USD 2900.00
(Single User License)
The global market for Birth Control Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 89
USD 3950.00
(Single User License)
The birth control patch is a contraceptive device that contains the hormones estrogen and progestin.
Published Date: 2024-04-25
Pages: 93
USD 4900.00
(Single User License)
The birth control patch is a contraceptive device that contains the hormones estrogen and progestin.
Published Date: 2024-01-11
Pages: 101
USD 3950.00
(Single User License)
The global Birth Control Patch market was valued at US$ 17.52 million in 2025 and is anticipated to reach US$ 42.03 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 93
The global Birth Control Patch market size was US$ 17.52 million in 2025 and is forecast to reach a readjusted size of US$ 42.03 million by 2032 with a CAGR of 13.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 67
The global market for Birth Control Patch was estimated to be worth US$ 17.52 million in 2025 and is projected to reach US$ 42.03 million, growing at a CAGR of 13.5% from 2026 to 2032.
Published: 2026-03-06
Pages: 89
The global Birth Control Patch market size was US$ 14.78 million in 2024 and is forecast to a readjusted size of US$ 37.47 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 72
The global Birth Control Patch market is projected to grow from US$ 14.78 million in 2024 to US$ 37.47 million by 2031, at a CAGR of 13.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-12-12
Pages: 115
The global market for Birth Control Patch was valued at US$ 14.78 million in the year 2024 and is projected to reach a revised size of US$ 37.47 million by 2031, growing at a CAGR of 13.5% during the forecast period.
Published: 2025-12-12
Pages: 104
The global market for Birth Control Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 89
The birth control patch is a contraceptive device that contains the hormones estrogen and progestin.
Published: 2024-04-25
Pages: 93
The birth control patch is a contraceptive device that contains the hormones estrogen and progestin.
Published: 2024-01-11
Pages: 101
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now